Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Needs To Balance Equal Access To Affordable Medicines With Sharpening Focus On Innovative Drugs In Mapping Out Future, Say Leaders At DIA Conference

This article was originally published in PharmAsia News

Executive Summary

BEIJING - As China launches sweeping health system reforms in phases over the next decade, the country must balance competing interests in mapping out the future: laying the groundwork for affordable and ultimately universal coverage while promoting the development of research- and capital-intensive innovative medicines, according to drug industry, academic and policy-making leaders who provided glimpses of the road ahead during the second annual meeting of the Drug Information Association in China

You may also be interested in...

China's Health Reform Will Nurture New Drugs, While Boosting Use Of Old Ones - PharmAsia Summit

SAN FRANCISCO - In addition to dramatically increasing access to mainly generic drugs, China's sweeping and upcoming health reform will also include measures designed to spur R&D, according to Song Ruilin, Executive Director-General at the Chinese Pharmaceutical Association's Research Center for Medicinal Policy

China Paring Down Essential Medicines List In Sweeping Health System Reforms

[Editor's note: This is part three in a new series on China's wide-ranging plans to reform the country's health system, including its hospitals, insurance schemes, and access to medicines. Part one in the series appeared in PharmAsia News Oct. 30, 2008, and part two appeared Nov. 13, 2008.]

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts